0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Structural Heart Diseases Device Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-22P12118
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Structural Heart Diseases Device Market Research Report 2022
BUY CHAPTERS

Global Structural Heart Diseases Device Market Research Report 2025

Code: QYRE-Auto-22P12118
Report
February 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Structural Heart Diseases Device Market Size

The global market for Structural Heart Diseases Device was valued at US$ 15490 million in the year 2024 and is projected to reach a revised size of US$ 28980 million by 2031, growing at a CAGR of 9.5% during the forecast period.

Structural Heart Diseases Device Market

Structural Heart Diseases Device Market

Structural heart devices comprise annuloplasty rings, heart valve balloons occluders among others. These devices are used to reshape and tighten the ring around the heart, in case the heart is enlarged or has a leaky valve.
The structural heart diseases device market is driven by the growing prevalence of structural heart diseases and the increasing demand for innovative and minimally invasive treatment options. Structural heart diseases devices are medical devices used to treat abnormalities or defects in the heart"s structure, such as valve disorders or congenital heart defects. The rise in the aging population and the incidence of heart-related conditions contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of novel devices have improved the effectiveness and safety of structural heart disease treatments. However, the market also faces challenges, including the high cost of some devices and the need for rigorous clinical trials and regulatory approvals for new treatments. Additionally, addressing reimbursement issues and competing with conventional surgical approaches can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer cutting-edge structural heart diseases devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for effective and minimally invasive solutions for structural heart diseases.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Structural Heart Diseases Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Structural Heart Diseases Device.
The Structural Heart Diseases Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Structural Heart Diseases Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Structural Heart Diseases Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Structural Heart Diseases Device Market Report

Report Metric Details
Report Name Structural Heart Diseases Device Market
Accounted market size in year US$ 15490 million
Forecasted market size in 2031 US$ 28980 million
CAGR 9.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort, Edwards Lifesciences, Medtronic, Venus Medtech, Meril Life Sciences, Braile Biomedica
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Structural Heart Diseases Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Structural Heart Diseases Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Structural Heart Diseases Device Market growing?

Ans: The Structural Heart Diseases Device Market witnessing a CAGR of 9.5% during the forecast period 2025-2031.

What is the Structural Heart Diseases Device Market size in 2031?

Ans: The Structural Heart Diseases Device Market size in 2031 will be US$ 28980 million.

Who are the main players in the Structural Heart Diseases Device Market report?

Ans: The main players in the Structural Heart Diseases Device Market are Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort, Edwards Lifesciences, Medtronic, Venus Medtech, Meril Life Sciences, Braile Biomedica

What are the Application segmentation covered in the Structural Heart Diseases Device Market report?

Ans: The Applications covered in the Structural Heart Diseases Device Market report are Hospitals, Clinics

What are the Type segmentation covered in the Structural Heart Diseases Device Market report?

Ans: The Types covered in the Structural Heart Diseases Device Market report are CHD Occluder, Cardioembolic Stroke Occluder, Heart Valve, Other

Recommended Reports

Heart Valve Devices

Balloon & Occluder Devices

Structural Heart Devices

1 Structural Heart Diseases Device Market Overview
1.1 Product Definition
1.2 Structural Heart Diseases Device by Type
1.2.1 Global Structural Heart Diseases Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 CHD Occluder
1.2.3 Cardioembolic Stroke Occluder
1.2.4 Heart Valve
1.2.5 Other
1.3 Structural Heart Diseases Device by Application
1.3.1 Global Structural Heart Diseases Device Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Structural Heart Diseases Device Market Size Estimates and Forecasts
1.4.1 Global Structural Heart Diseases Device Revenue 2020-2031
1.4.2 Global Structural Heart Diseases Device Sales 2020-2031
1.4.3 Global Structural Heart Diseases Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Structural Heart Diseases Device Market Competition by Manufacturers
2.1 Global Structural Heart Diseases Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Structural Heart Diseases Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Structural Heart Diseases Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Structural Heart Diseases Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Structural Heart Diseases Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Structural Heart Diseases Device, Product Type & Application
2.7 Global Key Manufacturers of Structural Heart Diseases Device, Date of Enter into This Industry
2.8 Global Structural Heart Diseases Device Market Competitive Situation and Trends
2.8.1 Global Structural Heart Diseases Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Structural Heart Diseases Device Players Market Share by Revenue
2.8.3 Global Structural Heart Diseases Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Structural Heart Diseases Device Market Scenario by Region
3.1 Global Structural Heart Diseases Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Structural Heart Diseases Device Sales by Region: 2020-2031
3.2.1 Global Structural Heart Diseases Device Sales by Region: 2020-2025
3.2.2 Global Structural Heart Diseases Device Sales by Region: 2026-2031
3.3 Global Structural Heart Diseases Device Revenue by Region: 2020-2031
3.3.1 Global Structural Heart Diseases Device Revenue by Region: 2020-2025
3.3.2 Global Structural Heart Diseases Device Revenue by Region: 2026-2031
3.4 North America Structural Heart Diseases Device Market Facts & Figures by Country
3.4.1 North America Structural Heart Diseases Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Structural Heart Diseases Device Sales by Country (2020-2031)
3.4.3 North America Structural Heart Diseases Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Structural Heart Diseases Device Market Facts & Figures by Country
3.5.1 Europe Structural Heart Diseases Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Structural Heart Diseases Device Sales by Country (2020-2031)
3.5.3 Europe Structural Heart Diseases Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Structural Heart Diseases Device Market Facts & Figures by Region
3.6.1 Asia Pacific Structural Heart Diseases Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Structural Heart Diseases Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Structural Heart Diseases Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Structural Heart Diseases Device Market Facts & Figures by Country
3.7.1 Latin America Structural Heart Diseases Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Structural Heart Diseases Device Sales by Country (2020-2031)
3.7.3 Latin America Structural Heart Diseases Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Structural Heart Diseases Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Structural Heart Diseases Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Structural Heart Diseases Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Structural Heart Diseases Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Structural Heart Diseases Device Sales by Type (2020-2031)
4.1.1 Global Structural Heart Diseases Device Sales by Type (2020-2025)
4.1.2 Global Structural Heart Diseases Device Sales by Type (2026-2031)
4.1.3 Global Structural Heart Diseases Device Sales Market Share by Type (2020-2031)
4.2 Global Structural Heart Diseases Device Revenue by Type (2020-2031)
4.2.1 Global Structural Heart Diseases Device Revenue by Type (2020-2025)
4.2.2 Global Structural Heart Diseases Device Revenue by Type (2026-2031)
4.2.3 Global Structural Heart Diseases Device Revenue Market Share by Type (2020-2031)
4.3 Global Structural Heart Diseases Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Structural Heart Diseases Device Sales by Application (2020-2031)
5.1.1 Global Structural Heart Diseases Device Sales by Application (2020-2025)
5.1.2 Global Structural Heart Diseases Device Sales by Application (2026-2031)
5.1.3 Global Structural Heart Diseases Device Sales Market Share by Application (2020-2031)
5.2 Global Structural Heart Diseases Device Revenue by Application (2020-2031)
5.2.1 Global Structural Heart Diseases Device Revenue by Application (2020-2025)
5.2.2 Global Structural Heart Diseases Device Revenue by Application (2026-2031)
5.2.3 Global Structural Heart Diseases Device Revenue Market Share by Application (2020-2031)
5.3 Global Structural Heart Diseases Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Structural Heart Diseases Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Structural Heart Diseases Device Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 LifeTech
6.3.1 LifeTech Company Information
6.3.2 LifeTech Description and Business Overview
6.3.3 LifeTech Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 LifeTech Structural Heart Diseases Device Product Portfolio
6.3.5 LifeTech Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Company Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lepu Medical Structural Heart Diseases Device Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 Occlutech
6.5.1 Occlutech Company Information
6.5.2 Occlutech Description and Business Overview
6.5.3 Occlutech Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Occlutech Structural Heart Diseases Device Product Portfolio
6.5.5 Occlutech Recent Developments/Updates
6.6 W. L. Gore & Associates
6.6.1 W. L. Gore & Associates Company Information
6.6.2 W. L. Gore & Associates Description and Business Overview
6.6.3 W. L. Gore & Associates Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 W. L. Gore & Associates Structural Heart Diseases Device Product Portfolio
6.6.5 W. L. Gore & Associates Recent Developments/Updates
6.7 Starway
6.7.1 Starway Company Information
6.7.2 Starway Description and Business Overview
6.7.3 Starway Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Starway Structural Heart Diseases Device Product Portfolio
6.7.5 Starway Recent Developments/Updates
6.8 Coherex Medical
6.8.1 Coherex Medical Company Information
6.8.2 Coherex Medical Description and Business Overview
6.8.3 Coherex Medical Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Coherex Medical Structural Heart Diseases Device Product Portfolio
6.8.5 Coherex Medical Recent Developments/Updates
6.9 Cardia
6.9.1 Cardia Company Information
6.9.2 Cardia Description and Business Overview
6.9.3 Cardia Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cardia Structural Heart Diseases Device Product Portfolio
6.9.5 Cardia Recent Developments/Updates
6.10 MicroPort
6.10.1 MicroPort Company Information
6.10.2 MicroPort Description and Business Overview
6.10.3 MicroPort Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MicroPort Structural Heart Diseases Device Product Portfolio
6.10.5 MicroPort Recent Developments/Updates
6.11 Edwards Lifesciences
6.11.1 Edwards Lifesciences Company Information
6.11.2 Edwards Lifesciences Description and Business Overview
6.11.3 Edwards Lifesciences Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Edwards Lifesciences Structural Heart Diseases Device Product Portfolio
6.11.5 Edwards Lifesciences Recent Developments/Updates
6.12 Medtronic
6.12.1 Medtronic Company Information
6.12.2 Medtronic Description and Business Overview
6.12.3 Medtronic Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Medtronic Structural Heart Diseases Device Product Portfolio
6.12.5 Medtronic Recent Developments/Updates
6.13 Venus Medtech
6.13.1 Venus Medtech Company Information
6.13.2 Venus Medtech Description and Business Overview
6.13.3 Venus Medtech Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Venus Medtech Structural Heart Diseases Device Product Portfolio
6.13.5 Venus Medtech Recent Developments/Updates
6.14 Meril Life Sciences
6.14.1 Meril Life Sciences Company Information
6.14.2 Meril Life Sciences Description and Business Overview
6.14.3 Meril Life Sciences Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Meril Life Sciences Structural Heart Diseases Device Product Portfolio
6.14.5 Meril Life Sciences Recent Developments/Updates
6.15 Braile Biomedica
6.15.1 Braile Biomedica Company Information
6.15.2 Braile Biomedica Description and Business Overview
6.15.3 Braile Biomedica Structural Heart Diseases Device Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Braile Biomedica Structural Heart Diseases Device Product Portfolio
6.15.5 Braile Biomedica Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Structural Heart Diseases Device Industry Chain Analysis
7.2 Structural Heart Diseases Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Structural Heart Diseases Device Production Mode & Process Analysis
7.4 Structural Heart Diseases Device Sales and Marketing
7.4.1 Structural Heart Diseases Device Sales Channels
7.4.2 Structural Heart Diseases Device Distributors
7.5 Structural Heart Diseases Device Customer Analysis
8 Structural Heart Diseases Device Market Dynamics
8.1 Structural Heart Diseases Device Industry Trends
8.2 Structural Heart Diseases Device Market Drivers
8.3 Structural Heart Diseases Device Market Challenges
8.4 Structural Heart Diseases Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Structural Heart Diseases Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Structural Heart Diseases Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Structural Heart Diseases Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Structural Heart Diseases Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Structural Heart Diseases Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Structural Heart Diseases Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Structural Heart Diseases Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Structural Heart Diseases Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Structural Heart Diseases Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Structural Heart Diseases Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Structural Heart Diseases Device, Product Type & Application
 Table 12. Global Key Manufacturers of Structural Heart Diseases Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Structural Heart Diseases Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Structural Heart Diseases Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Structural Heart Diseases Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Structural Heart Diseases Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Structural Heart Diseases Device Sales Market Share by Region (2020-2025)
 Table 19. Global Structural Heart Diseases Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Structural Heart Diseases Device Sales Market Share by Region (2026-2031)
 Table 21. Global Structural Heart Diseases Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Structural Heart Diseases Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Structural Heart Diseases Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Structural Heart Diseases Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Structural Heart Diseases Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Structural Heart Diseases Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Structural Heart Diseases Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Structural Heart Diseases Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Structural Heart Diseases Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Structural Heart Diseases Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Structural Heart Diseases Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Structural Heart Diseases Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Structural Heart Diseases Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Structural Heart Diseases Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Structural Heart Diseases Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Structural Heart Diseases Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Structural Heart Diseases Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Structural Heart Diseases Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Structural Heart Diseases Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Structural Heart Diseases Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Structural Heart Diseases Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Structural Heart Diseases Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Structural Heart Diseases Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Structural Heart Diseases Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Structural Heart Diseases Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Structural Heart Diseases Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Structural Heart Diseases Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Structural Heart Diseases Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Structural Heart Diseases Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Structural Heart Diseases Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Structural Heart Diseases Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Structural Heart Diseases Device Sales Market Share by Type (2020-2025)
 Table 53. Global Structural Heart Diseases Device Sales Market Share by Type (2026-2031)
 Table 54. Global Structural Heart Diseases Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Structural Heart Diseases Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Structural Heart Diseases Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Structural Heart Diseases Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Structural Heart Diseases Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Structural Heart Diseases Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Structural Heart Diseases Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Structural Heart Diseases Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Structural Heart Diseases Device Sales Market Share by Application (2020-2025)
 Table 63. Global Structural Heart Diseases Device Sales Market Share by Application (2026-2031)
 Table 64. Global Structural Heart Diseases Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Structural Heart Diseases Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Structural Heart Diseases Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Structural Heart Diseases Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Structural Heart Diseases Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Structural Heart Diseases Device Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Structural Heart Diseases Device Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Boston Scientific Company Information
 Table 76. Boston Scientific Description and Business Overview
 Table 77. Boston Scientific Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boston Scientific Structural Heart Diseases Device Product
 Table 79. Boston Scientific Recent Developments/Updates
 Table 80. LifeTech Company Information
 Table 81. LifeTech Description and Business Overview
 Table 82. LifeTech Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. LifeTech Structural Heart Diseases Device Product
 Table 84. LifeTech Recent Developments/Updates
 Table 85. Lepu Medical Company Information
 Table 86. Lepu Medical Description and Business Overview
 Table 87. Lepu Medical Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lepu Medical Structural Heart Diseases Device Product
 Table 89. Lepu Medical Recent Developments/Updates
 Table 90. Occlutech Company Information
 Table 91. Occlutech Description and Business Overview
 Table 92. Occlutech Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Occlutech Structural Heart Diseases Device Product
 Table 94. Occlutech Recent Developments/Updates
 Table 95. W. L. Gore & Associates Company Information
 Table 96. W. L. Gore & Associates Description and Business Overview
 Table 97. W. L. Gore & Associates Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. W. L. Gore & Associates Structural Heart Diseases Device Product
 Table 99. W. L. Gore & Associates Recent Developments/Updates
 Table 100. Starway Company Information
 Table 101. Starway Description and Business Overview
 Table 102. Starway Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Starway Structural Heart Diseases Device Product
 Table 104. Starway Recent Developments/Updates
 Table 105. Coherex Medical Company Information
 Table 106. Coherex Medical Description and Business Overview
 Table 107. Coherex Medical Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Coherex Medical Structural Heart Diseases Device Product
 Table 109. Coherex Medical Recent Developments/Updates
 Table 110. Cardia Company Information
 Table 111. Cardia Description and Business Overview
 Table 112. Cardia Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Cardia Structural Heart Diseases Device Product
 Table 114. Cardia Recent Developments/Updates
 Table 115. MicroPort Company Information
 Table 116. MicroPort Description and Business Overview
 Table 117. MicroPort Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. MicroPort Structural Heart Diseases Device Product
 Table 119. MicroPort Recent Developments/Updates
 Table 120. Edwards Lifesciences Company Information
 Table 121. Edwards Lifesciences Description and Business Overview
 Table 122. Edwards Lifesciences Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Edwards Lifesciences Structural Heart Diseases Device Product
 Table 124. Edwards Lifesciences Recent Developments/Updates
 Table 125. Medtronic Company Information
 Table 126. Medtronic Description and Business Overview
 Table 127. Medtronic Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Medtronic Structural Heart Diseases Device Product
 Table 129. Medtronic Recent Developments/Updates
 Table 130. Venus Medtech Company Information
 Table 131. Venus Medtech Description and Business Overview
 Table 132. Venus Medtech Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Venus Medtech Structural Heart Diseases Device Product
 Table 134. Venus Medtech Recent Developments/Updates
 Table 135. Meril Life Sciences Company Information
 Table 136. Meril Life Sciences Description and Business Overview
 Table 137. Meril Life Sciences Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Meril Life Sciences Structural Heart Diseases Device Product
 Table 139. Meril Life Sciences Recent Developments/Updates
 Table 140. Braile Biomedica Company Information
 Table 141. Braile Biomedica Description and Business Overview
 Table 142. Braile Biomedica Structural Heart Diseases Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Braile Biomedica Structural Heart Diseases Device Product
 Table 144. Braile Biomedica Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Structural Heart Diseases Device Distributors List
 Table 148. Structural Heart Diseases Device Customers List
 Table 149. Structural Heart Diseases Device Market Trends
 Table 150. Structural Heart Diseases Device Market Drivers
 Table 151. Structural Heart Diseases Device Market Challenges
 Table 152. Structural Heart Diseases Device Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Structural Heart Diseases Device
 Figure 2. Global Structural Heart Diseases Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Structural Heart Diseases Device Market Share by Type: 2024 & 2031
 Figure 4. CHD Occluder Product Picture
 Figure 5. Cardioembolic Stroke Occluder Product Picture
 Figure 6. Heart Valve Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Structural Heart Diseases Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Structural Heart Diseases Device Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Global Structural Heart Diseases Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Structural Heart Diseases Device Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Structural Heart Diseases Device Sales (2020-2031) & (K Units)
 Figure 15. Global Structural Heart Diseases Device Average Price (US$/Unit) & (2020-2031)
 Figure 16. Structural Heart Diseases Device Report Years Considered
 Figure 17. Structural Heart Diseases Device Sales Share by Manufacturers in 2024
 Figure 18. Global Structural Heart Diseases Device Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Structural Heart Diseases Device Players: Market Share by Revenue in Structural Heart Diseases Device in 2024
 Figure 20. Structural Heart Diseases Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Structural Heart Diseases Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Structural Heart Diseases Device Sales Market Share by Country (2020-2031)
 Figure 23. North America Structural Heart Diseases Device Revenue Market Share by Country (2020-2031)
 Figure 24. United States Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Structural Heart Diseases Device Sales Market Share by Country (2020-2031)
 Figure 27. Europe Structural Heart Diseases Device Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Structural Heart Diseases Device Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Structural Heart Diseases Device Revenue Market Share by Region (2020-2031)
 Figure 35. China Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Structural Heart Diseases Device Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Structural Heart Diseases Device Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Structural Heart Diseases Device Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Structural Heart Diseases Device Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Structural Heart Diseases Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Structural Heart Diseases Device by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Structural Heart Diseases Device by Type (2020-2031)
 Figure 54. Global Structural Heart Diseases Device Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Structural Heart Diseases Device by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Structural Heart Diseases Device by Application (2020-2031)
 Figure 57. Global Structural Heart Diseases Device Price (US$/Unit) by Application (2020-2031)
 Figure 58. Structural Heart Diseases Device Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart